SG11201909366XA - Method for preparing and analyzing fluorescent compounds in plasma - Google Patents

Method for preparing and analyzing fluorescent compounds in plasma

Info

Publication number
SG11201909366XA
SG11201909366XA SG11201909366XA SG11201909366XA SG 11201909366X A SG11201909366X A SG 11201909366XA SG 11201909366X A SG11201909366X A SG 11201909366XA SG 11201909366X A SG11201909366X A SG 11201909366XA
Authority
SG
Singapore
Prior art keywords
international
plasma
sample
analyzing
pct
Prior art date
Application number
Other languages
English (en)
Inventor
Jeng J Shieh
Original Assignee
Medibeacon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medibeacon Inc filed Critical Medibeacon Inc
Publication of SG11201909366XA publication Critical patent/SG11201909366XA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/16—Injection
    • G01N30/22—Injection in high pressure liquid systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation
    • G01N30/14—Preparation by elimination of some components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D229/00—Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/38—Diluting, dispersing or mixing samples
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8822—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/884—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/74—Optical detectors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Fluid Mechanics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201909366X 2017-11-20 2018-11-15 Method for preparing and analyzing fluorescent compounds in plasma SG11201909366XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762588606P 2017-11-20 2017-11-20
PCT/US2018/061282 WO2019099672A1 (en) 2017-11-20 2018-11-15 Method for preparing and analyzing fluorescent compounds in plasma

Publications (1)

Publication Number Publication Date
SG11201909366XA true SG11201909366XA (en) 2019-11-28

Family

ID=66532776

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201909366X SG11201909366XA (en) 2017-11-20 2018-11-15 Method for preparing and analyzing fluorescent compounds in plasma

Country Status (16)

Country Link
US (1) US11674965B2 (es)
EP (1) EP3713577A4 (es)
JP (1) JP2020516692A (es)
KR (2) KR20200007778A (es)
CN (1) CN110461332A (es)
AU (1) AU2018369913B2 (es)
BR (1) BR112019021044A2 (es)
CA (1) CA3058762A1 (es)
IL (1) IL269611A (es)
MX (1) MX2019011901A (es)
MY (1) MY188418A (es)
PH (1) PH12019502373A1 (es)
RU (1) RU2746503C1 (es)
SG (1) SG11201909366XA (es)
WO (1) WO2019099672A1 (es)
ZA (1) ZA201906445B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113109491A (zh) * 2020-01-13 2021-07-13 四川基因格司法鉴定中心 从生物样本中检测毒药物的通用方法
TW202233586A (zh) * 2020-11-10 2022-09-01 美商麥迪貝肯有限公司 吡𠯤化合物的皮下與肌內注射
EP4313172A1 (en) * 2021-03-31 2024-02-07 Medibeacon Inc. Preparation of substituted diaminopyrazine dicarboxylic acids
US20220315538A1 (en) * 2021-03-31 2022-10-06 Medibeacon Inc. Purification of substituted diaminopyrazine dicarboxylic acids
TW202321203A (zh) * 2021-08-11 2023-06-01 中國大陸商杭州中美華東製藥有限公司 製備作為螢光示蹤劑的吡嗪羧酸類衍生物的方法
CN117881665A (zh) * 2021-08-27 2024-04-12 杭州中美华东制药有限公司 吡嗪类衍生物的晶型及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4647742B2 (ja) * 2000-03-13 2011-03-09 三菱化学メディエンス株式会社 アスコルビン酸の分析方法及び分析用試薬
US6969592B2 (en) * 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
US6909912B2 (en) 2002-06-20 2005-06-21 University Of Florida Non-invasive perfusion monitor and system, specially configured oximeter probes, methods of using same, and covers for probes
AU2004233870B2 (en) 2003-04-24 2009-11-05 The Board Of Regents Of The University Of Texas System Noninvasive blood analysis by optical probing of the veins under the tongue
US20060095102A1 (en) 2003-09-17 2006-05-04 Thomas Perez Method and apparatus for sublingual application of light to blood
JP4214109B2 (ja) * 2004-12-16 2009-01-28 日本ハム株式会社 畜水産物中の残留動物用薬剤の抽出液
DE602005020981D1 (de) 2004-12-23 2010-06-10 Mallinckrodt Inc Fluoreszente pyrazinderivate und verfahren zu deren anwendung bei der bewertung der nierenfunktion
DK2029554T3 (da) 2006-06-22 2014-06-10 Medibeacon Llc Pyrazinderivater og anvendelser heraf til nyreovervågning
EP2139485B1 (en) * 2007-04-11 2012-10-17 BioMarin Pharmaceutical Inc. Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
CN102770751A (zh) 2010-02-23 2012-11-07 B.R.A.H.M.S有限公司 测定小体积体液样品中的标志物的方法
US20120172677A1 (en) 2010-12-30 2012-07-05 Logan Robert J Systems and methods for monitoring and processing biometric data
AU2012249600B2 (en) 2011-04-26 2016-05-19 Incube Labs, Llc Mouthpiece for measurement of biometric data of a diver and underwater communication
WO2016183351A1 (en) 2015-05-12 2016-11-17 Medibeacon Inc. Compositions and methods for assessing eye vasculature

Also Published As

Publication number Publication date
WO2019099672A1 (en) 2019-05-23
RU2746503C1 (ru) 2021-04-14
US11674965B2 (en) 2023-06-13
AU2018369913B2 (en) 2020-08-20
BR112019021044A2 (pt) 2020-05-12
MX2019011901A (es) 2019-12-05
AU2018369913A1 (en) 2019-10-17
US20190154697A1 (en) 2019-05-23
KR20220021024A (ko) 2022-02-21
EP3713577A1 (en) 2020-09-30
CA3058762A1 (en) 2019-05-23
MY188418A (en) 2021-12-08
PH12019502373A1 (en) 2020-07-13
ZA201906445B (en) 2020-08-26
KR20200007778A (ko) 2020-01-22
CN110461332A (zh) 2019-11-15
EP3713577A4 (en) 2021-08-18
JP2020516692A (ja) 2020-06-11
IL269611A (en) 2019-11-28

Similar Documents

Publication Publication Date Title
SG11201909366XA (en) Method for preparing and analyzing fluorescent compounds in plasma
SG11201804086VA (en) Methods and compositions for nucleic acid analysis
SG11201807784SA (en) 3-desoxy derivative and pharmaceutical compositions thereof
SG11201808990QA (en) Compositions for topical application of compounds
SG11201809344QA (en) Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
SG11201902938TA (en) Compounds, devices, and uses thereof
SG11201804758QA (en) Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab
SG11201909963YA (en) Methods for treating dravet syndrome
SG11201907023UA (en) Method of reducing neutropenia
SG11201906238TA (en) Split sector level sweep using beamforming refinement frames
SG11201900554YA (en) Spiro-lactam nmda modulators and methods of using same
SG11201908325PA (en) Process for the preparation of glucuronide drug-linkers and intermediates thereof
SG11201908847TA (en) Apparatuses, systems and methods for imaging flow cytometry
SG11201811230RA (en) Compositions and methods for reducing ocular neovascularization
SG11201808713YA (en) Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier
SG11202000333UA (en) Bicyclic ketone compounds and methods of use thereof
SG11201804050QA (en) A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
SG11201901438VA (en) Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate
SG11201805149XA (en) Compositions comprising 15-hepe and methods of using the same
SG11201901394XA (en) Neisseria meningitidis vaccine
SG11201408273TA (en) Time synchronizing of distinct video and data feeds that are delivered in a single mobile ip data network compatible stream
SG11201808298QA (en) Cannula capture mechanism
SG11201806432PA (en) Methods for assessing risk of developing colorectal cancer
SG11201909495PA (en) Combination cancer immunotherapy with pentaaza macrocyclic ring complex
SG11201804048WA (en) A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic